Log In
Print this Print this

Taxus Element Stent

  Manage Alerts
Collapse Summary General Information
Company Boston Scientific Corp.
DescriptionThird-generation paclitaxel-eluting coronary stent
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD) in patients with diabetes; Treat de novo coronary artery lesions
Regulatory Designation
PartnerAngiotech Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today